Shares of Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +1.08% slipped 0.51% to $71.88 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.81% falling 1.42% to 4,659.03 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.15% falling 0.49% to 36,113.62. This was the stock's second consecutive day of losses. Gilead Sciences Inc. closed $2.24 short of its 52-week high ($74.12), which the company reached on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.09% fell 0.61% to $168.76, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.86% rose 0.15% to $81.32, and AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.73% fell 1.74% to $133.52. Trading volume (6.7 M) remained 397,662 below its 50-day average volume of 7.1 M.